Cited by 561Ovarian function and disordersMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Open access

Dunaif, A, Xia, J, Book, C B, Schenker, E, Tang, Z·1995·Journal of Clinical Investigation

DOI 10.1172/jci118126PMC PMC185266

Open this paper in CoChat — free account Open PDF

Abstract

We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent beta-subunit [32P]phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-n1) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-n1 receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci118126

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L., Dull, T. J., Gray, A., Coussens, L. M., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citation
Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.
Ullrich, A., Gray, A., Tam, A. W., Yang‐Feng, T. L., Tsubokawa, M., Collins, C. M., Henzel, W. J., Bon, T. L., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,843
[42] Detection and quantification of phosphotyrosine in proteins
Cooper, J. A., Sefton, B. M., & Hunter, T. R. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)99075-4 · Cited by 1,109
Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
POLSON, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 899
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624

Flagged first, then by citations

Show all 71 references

Sorted by citations

Items 301–400 of 559

Serum Fetuin-A levels in women with polycystic ovary syndrome
Gülhan, İ., Bozkaya, G., Öztekin, D. C., Uyar, İ., Kebapçılar, A. G., & Pamuk, B. Ö. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2494-0 · Cited by 21
Body fluid volume status in hemodialysis patients: the value of the chest radiograph.
Don, C., Burns, K. D., & Levine, D. Z. (1990) · PubMed · Cited by 21
Polycystic ovary syndrome in adolescent girls
Pfeifer, S. M. (2005) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2005.01.007 · Cited by 21
Polycystic Ovary Syndrome Hyperandrogenism, and Insulin Resistance
Zacur, H. A. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70183-2 · Cited by 21
Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
Hwang, K. R., Choi, Y. M., Kim, J., Chae, S. J., Park, K. E., Jeon, H. W., Ku, S., Kim, S. H., Kim, J. G., & Moon, S. Y. (2013) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2013.40.2.100 · Cited by 20
Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome
Takeuchi, T., Tsutsumi, O., & Taketani, Y. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802173584 · Cited by 20
Neonatal hypothalamic androgenization in the female rat induces changes in peripheral insulin sensitivity and adiposity function at adulthood.
Perelló, M., Castrogiovanni, D. C., Moreno, G., Gaillard, R. C., & Spinedi, E. (2003) · PubMed · Cited by 20
PATHOPHYSIOLOGY, GENETICS, AND TREATMENT OF HYPERANDROGENISM
Miller, W. L. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70482-x · Cited by 20
Lean mass and associated factors in women with PCOS with different phenotypes
Fighera, T. M., dos Santos, B. R., & Spritzer, P. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292623 · Cited by 19
Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
Connolly, A., Leblanc, S., & Baillargeon, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4315413 · Cited by 19
Excess androgen production in subcutaneous adipose tissue of women with polycystic ovarian syndrome is not related to insulin or LH
Amer, S. A. K. S., Alzanati, N. G., Warren, A., Tarbox, R., & Khan, R. N. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0674 · Cited by 19
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
Effects of Intrabrachial Metacholine Infusion on Muscle Capillary Recruitment and Forearm Glucose Uptake during Physiological Hyperinsulinemia in Obese, Insulin-Resistant Individuals
Murdolo, G., Sjöstrand, M., Strindberg, L., Guðbjörnsdóttir, S., Lind, L., Lönnroth, P., & Jansson, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2737 · Cited by 19
Polycystic Ovary Syndrome
Zweig, S. B., Tolentino, M. C., & Poretsky, L. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_38 · Cited by 19
Insulin resistance and polycystic ovary syndrome
Ehrmann, D. A. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0061-y · Cited by 19
17α-Hydroxylase/17,20-Lyase Dysregulation Is Not Caused by Mutations in the Coding Regions of CYP17
Witchel, S. F., Lee, P. A., Suda-Hartman, M., Smith, R. R., & Hoffman, E. P. (1998) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(98)70132-9 · Cited by 19
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Albardan, L., Platat, C., & Kalupahana, N. S. (2024) · Nutrients · doi:10.3390/nu16172961 · Cited by 18
“To this end, cultured fibroblasts and skeletal muscle from women with PCOS showed increased serine phosphorylation and decreased tyrosine phosphorylation of the insulin receptor, suggesting another mechanism for insulin resistance [24].”
Background
111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women
Lee, J. Y., Lee, W. J., Hur, S. E., Lee, C. M., Sung, Y., & Chung, H. W. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.023 · Cited by 18
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
Elkind-Hirsch, K. E. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605030-00005 · Cited by 18
Use of Metformin for Ovulation Induction in Women Who Have Polycystic Ovary Syndrome With or Without Evidence of Insulin Resistance
Liu, K. E., TATARYN, I. V., & Sagle, M. A. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32202-2 · Cited by 18
Efficacy of Myo-inositol on anthropometric, metabolic, and endocrine outcomes in PCOS patients: a meta-analysis of randomized controlled trial
Jethaliya, H., Gajjar, N., Patel, V., Deshpande, S., & Patel, R. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00933-y · Cited by 17
Normal Metabolic Flexibility despite Insulin Resistance Women with Polycystic Ovary Syndrome
Adamska, A., Karczewska-Kupczewska, M., Nikolajuk, A., Otziomek, E., Górska, M., Kowalska, I., & Straczkowski, M. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0115 · Cited by 17
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Mechanism and recent updates on insulin-related disorders
Kumar, S., Senapati, S., Bhattacharya, N., Bhattacharya, A., Maurya, S. K., Husain, H., Bhatti, J. S., & Pandey, A. K. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i25.5840 · Cited by 17
Disorders of Energy Balance
Lustig, R. H., & Weiss, R. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50024-7 · Cited by 17
Polycystic Ovary Syndrome and Gender Identity.
Liu, M., Murthi, S., & Poretsky, L. (2020) · PubMed Central · Cited by 17
Diagnosis and Treatment of Polycystic Ovarian Syndrome and Insulin Resistance
Fleischman, A., & Mansfield, J. (2005) · Pediatric Annals · doi:10.3928/0090-4481-20050901-13 · Cited by 17
Genetic analysis of candidate genes for the polycystic ovary syndrome
Urbanek, M., & Spielman, R. S. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00009 · Cited by 17
Alterations in the Insulin Signaling Pathway Induced by Immortalization and H-ras Transformation of Brown Adipocytes
Valverde, Á. M., Lorenzo, M., Teruel, T., & Benito, M. (1997) · Endocrinology · doi:10.1210/endo.138.8.5293 · Cited by 17
Recent advances in the treatment of polycystic ovary syndrome
Yıldız, B. O. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1295 · Cited by 16
Reimbursement of metformin for polycystic ovary syndrome
Milewicz, A. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0025 · Cited by 18
Polycystic ovary syndrome
Kovanci, E., & Buster, J. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.068 · Cited by 16
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Albert Renold Memorial Lecture: Molecular Background of Nutritionally Induced Insulin Resistance Leadingto Type 2 Diabetes – From Animal Models to Humans
Shafrir, E. (2001) · Journal of Diabetes Research · doi:10.1155/edr.2001.299 · Cited by 16
The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome
Elkholi, D. G. E. Y., & Nagy, H. M. (2014) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2014.02.001 · Cited by 16
Third Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2006) · Diabetes Care · doi:10.2337/dc06-zb09 · Cited by 16
Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome
Mansour, A., Hosseini, S., Larijani, B., & Mohajeri-Tehrani, M. R. (2016) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2016-422 · Cited by 15
Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome
Tepavčević, S., Milutinović, D. V., Μacut, D., Žakula, Z., Nikolič, M., Antić, I. B., Romić, S., Bjekić-Macut, J., Matić, G. M., & Korićanac, G. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.006 · Cited by 15
Importance of elevated insulin resistance, dyslipidemia and status of antioxidant vitamins in polycystic ovary disease
Naidu, J. N., Swapna, G. N., Kumar, A. N., Krishnamma, M., & Anitha, M. (2013) · Free Radicals and Antioxidants · doi:10.1016/j.fra.2013.03.001 · Cited by 15
Family-based analysis of INSR polymorphisms in Chinese PCOS
Du, J., Wang, J., Sun, X., Xu, X., Zhang, F., Wang, B., Shi, Y., & Chen, Z. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.03.028 · Cited by 15
The polycystic ovary syndrome: what does insulin resistance have to do with it?
Ben‐Shlomo, I. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62053-6 · Cited by 15
The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome
Lenarcik, A., Bidzińska−Speichert, B., & Tworowska-Bardzińska, U. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003686387 · Cited by 15
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Mutation analysis of theWNT-4gene in patients with polycystic ovary syndrome
Canto, P., Söderlund, D., Carranza‐Lira, S., & Méndez, J. P. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600911698 · Cited by 14
Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
Baillargeon, J., Iuorno, M. J., & Nestler, J. E. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00003 · Cited by 14
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
McDonnell, T., Cussen, L., McIlroy, M., & O’Reilly, M. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221113140 · Cited by 15
ASSOCIATION OF INSULIN RESISTANCE AND SERUM 25–OH VITAMIN-D IN INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Kumar, A. N. (2019) · Figshare · doi:10.6084/m9.figshare.8113250 · Cited by 13
Improved Responsiveness of PCOS Patients to Clomiphene After CYP17a Inhibitor
Hassan, H. A., El-Gezeiry, D., Nafaa, T. M., & Baghdady, I. (2001) · Journal of Assisted Reproduction and Genetics · doi:10.1023/a:1013165006406 · Cited by 13
Genetic variation in insulin‐induced kinase signaling
Wang, I. X., Ramrattan, G., & Cheung, V. G. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156250 · Cited by 13
Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome
Ünlühızarcı, K., Özocak, M., Tanrıverdi, F., Atmaca, H., & Keleştimur, F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.075 · Cited by 13
FEM1A is a candidate gene for polycystic ovary syndrome
Maher, J., Hines, R. S., Futterweit, W., Crawford, S., Lu, D., Shen, P., Oefner, P. J., Kazi, M. H., Wilson, J. G., Subauste, J. S., et al. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500431458 · Cited by 13
Current Developments in the Molecular Genetics of the Polycystic Ovary Syndrome
Franks, S., Gharani, N., Waterworth, D. M., Batty, S., White, D. M., Williamson, R., & McCarthy, M. I. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00018-6 · Cited by 13
Insulin Resistance in Polycystic Ovarian Disease
Bhatia, V. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000177251.15366.85 · Cited by 13
Proteomics and genomics: A hypothesis‐free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome
Escobar-Morreale, H. F., Insenser, M. R., Cortón, M., Millán, J. L. S., & Peral, B. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780031 · Cited by 12
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients
Stracquadanio, M., Ciotta, L., & Palumbo, M. A. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1418852 · Cited by 12
Resolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women
Morshedzadeh, N., Saedisomeolia, A., Djalali, M., Eshraghian, M. R., Hantoushzadeh, S., & Mahmoudi, M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.018 · Cited by 12
Early impaired β-cell function in chinese women with polycystic ovary syndrome.
Tao, T., Li, S., Zhao, A., Mao, X., & Liu, W. (2012) · Europe PMC (PubMed Central) · Cited by 12
Insulin Action in Polycystic Ovary Syndrome: In Vivo and In Vitro
Baillargeon, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_4 · Cited by 12
Role of GnRH drive in the pathophysiology of polycystic ovary syndrome
Leondires, M. P., & Berga, S. L. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347331 · Cited by 12
Insulin: does it induce follicular arrest in the rat ovary?
Kuşçu, N. K., Koyuncu, F. M., Özbilgin, K., Inan, S., Tuğlu, M. İ., & Karaer, Ö. (2002) · Gynecological Endocrinology · doi:10.1080/gye.16.5.361.364 · Cited by 12
A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways
Aronis, K. N., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.001 · Cited by 12
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review1
Faubert, J., Battista, M., & Baillargeon, J. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-0089 · Cited by 12
New approaches to insulin resistance in polycystic ovarian syndrome
Davison, R. M. (1998) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-199806000-00003 · Cited by 12
Molecular Mechanisms of Insulin Resistance in the Polycystic Ovary Syndrome
Ciaraldi, T. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_26 · Cited by 12
Polycystic ovary syndrome
Aydın, H. L., Dayan, B. S., & GÜNGÖR, N. D. (2023) · Journal of Controversies in Obstetrics & Gynecology and Pediatrics · doi:10.51271/jcogp-0015 · Cited by 12
PCOS - the many faces of a disorder in women and men
Lafcı, N. G., Yılmaz, B., & Yıldız, B. O. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02512-1 · Cited by 11
Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.
Calogero, A. E., Calabrò, V., Catanuso, M., Condorelli, R. A., & Vignera, S. L. (2011) · PubMed · doi:10.3275/7746 · Cited by 11
Thyroid Function and Volume are Associated with Anthropometric Measurements and Insulin Resistance in Egyptian Women with Polycystic Ovary Syndrome
El-Aziz, M. M. E. S. A., & El-Eshmawy, M. M. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000288 · Cited by 11
Clinical, Biochemical, and Hormonal Associations in Female Patients with Acne: A Study and Literature Review.
Mehta-Ambalal, S. R. (2017) · PubMed Central · Cited by 11
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb09 · Cited by 11
The Insulin Resistance of Polycystic Ovary Syndrome
Demissie, M., Legro, R. S., & Dunaif, A. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_26 · Cited by 11
Self-citation
Insulin Resistance Effects on Sex Hormones and Ovulation in the Polycystic Ovary Syndrome
Nestler, J. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_19 · Cited by 11
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: an evolutionary metabolic adaptation
Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2025) · Reproduction · doi:10.1530/rep-25-0021 · Cited by 11
The beneficial effects of tetracosanol on insulin-resistance by insulin receptor kinase sensibilisation
Hsu, C., Shih, H. Y., Chang, Y. C., Huang, Z. L., Tsai, M. J., Chia, Y., Chen, C., Lai, Y., & Weng, C. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.033 · Cited by 10
Obesity, metabolic syndrome, and disorders of energy balance
Weiss, R., & Lustig, R. H. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00031-7 · Cited by 9
Insulin resistance: what is its role in the polycystic ovary syndrome?
Moghetti, P. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00002 · Cited by 10
Hyperinsulinaemia and polycystic ovary syndrome
Conway, G. S. (2000) · Human Fertility · doi:10.1080/1464727002000198761 · Cited by 10
Polycystic ovary syndrome and epithelial-mesenchymal transition: Mendelian randomization and single-cell analysis insights
Liu, D., Liu, D., & Zhou, K. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01617-2 · Cited by 10
On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 11
Insulin resistance and its relation to inflammatory status and serum lipids among young women with PCOS
Asmathulla, S., Rupa, K., Kripa, S., & Rajarajeswari, R. (2013) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.5455/2320-1770.ijrcog20130913 · Cited by 9
Polycystic Ovarian Syndrome
Legro, R. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50030-6 · Cited by 9
Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome
Al‐Ozairi, E., Quinton, R., & Advani, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.041 · Cited by 9
Insulin-sensitising drugs for polycystic ovary syndrome
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub2 · Cited by 9
Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study
Cai, J., Yue, J., Lu, N., Li, S., Zheng, J., Huang, R., Jiang, Y., Shan, C., Liu, W., Ma, J., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020483 · Cited by 8
Utility of Hemoglobin-A1C in Nondiabetic Women With Polycystic Ovary Syndrome
Mortada, R. A., Comerford, K. B., Kallail, K. J., & Karakas, S. E. (2013) · Endocrine Practice · doi:10.4158/ep12123.or · Cited by 8
Polycystic Ovary Syndrome
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_33-1 · Cited by 8
SNP analysis of follistatin gene associated with polycystic ovarian syndrome
Kanakarajan, S. (2010) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s11013 · Cited by 8
Inhibition of MEK1 signaling pathway in the liver ameliorates insulin resistance
Ueyama, A., Ban, N., Fukazawa, M., Hirayama, T., Takeda, M., Yata, T., Muramatsu, H., Hoshino, M., Yamamoto, M., Matsuo, M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8264830 · Cited by 7
Phosphatidylinositol 3-kinase p85 regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome
Kim, J., Choi, Y. M., Hong, M. A., Hwang, S.-S., Yoon, S. H., Chae, S. J., Jee, B. C., Ku, S., Kim, J. G., & Moon, S. Y. (2009) · Human Reproduction · doi:10.1093/humrep/dep019 · Cited by 7
Polycystic Ovary Syndrome and Insulin Resistance: New Approaches to Management, including Exercise
Laredo, S., Hannah, M. E., Casper, R. F., Feig, D. S., Leiter, L. A., & Rodgers, C. D. (2001) · Journal SOGC · doi:10.1016/s0849-5831(16)31301-5 · Cited by 7
Genetic contributions to glucose intolerance in polycystic ovary syndrome
Ehrmann, D. A. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62106-2 · Cited by 7
Unraveling the riddle of insulin resistance
Goldfine, I. D. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90112-9 · Cited by 7
Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects
Rautio, K. (2006) · Cited by 7
Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
Poojari, P., PADGAONKAR, A., Paramanya, A., & Ali, A. H. (2022) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.39.1.49 · Cited by 6
Insulin Resistance and Bone Metabolism Markers in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study on Females from the Islamic University Medical Center
Aldhafiri, F. K., Abdelgawad, F. E., Bakri, G. M. M., & Saber, T. (2023) · Medicina · doi:10.3390/medicina59030593 · Cited by 6
Syndrome des ovaires polymicrokystiques
Robin, G., Proust-Richard, C., Jonard-Catteau, S., & Dewailly, D. (2007) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(07)35089-0 · Cited by 6
Pathophysiology of polycystic ovary syndrome
Raja, M. H. R., Javed, M. A., & Rehman, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00013-x · Cited by 6
EFFECT OF METFORMIN THERAPY IN FEMALE VISITING DERMATOLOGIST FOR ACNE VULGARIS HAVING ENDOCRINE AND SONOGRAPHIC CHARACTERISTICS OF POLYCYSTIC OVARY SYNDROME (PCOS)
Ty, M., Shah, & Rk, G. (2013) · Cited by 6
Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies
Garcia-Hernandez, S. C., Porchia, L. M., Pacheco-Soto, B. T., López‐Bayghen, E., & González-Mejía, M. E. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1913114 · Cited by 6
Peripubertal Hyperinsulinemia Upregulates Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Ovaries
Chakrabarty, S., & Nagamani, M. (2008) · Reproductive Sciences · doi:10.1177/1933719108316389 · Cited by 6

Authors: Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z.
Affiliations: Pennsylvania State University (US)
ORCID: Dunaif, A
Schenker, E
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1995-08-01
Volume: 96
Issue: 2
Pages: 801-810
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci118126
PMC: PMC185266
OpenAlex: W2124838987
Cited by: 561
References: 71
Citations by year: 2026: 3 · 2025: 15 · 2024: 7 · 2023: 17 · 2022: 20 · 2021: 18 · 2020: 15 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 19 · 2014: 18 · 2013: 23 · 2012: 21
FWCI: 18.65
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605, R01 DK-40605)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, insulin resistance, insulin receptor, serine phosphorylation, tyrosine phosphorylation, receptor autophosphorylation, protein tyrosine kinase activity, dermal fibroblasts, skeletal muscle, insulin signaling
MeSH terms: Adult, Blood Glucose, Cells, Cultured, Diabetes Mellitus, Type 2, Female, Fibroblasts, Humans, Insulin, Insulin Resistance, Obesity, Peptides, Phosphorylation, Phosphoserine, Polycystic Ovary Syndrome, Protein Processing, Post-Translational, Receptor, Insulin, Skin, Protein Serine-Threonine Kinases, Muscle, Skeletal, Intercellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks